The most striking result in the paper may actually be the 44% reduction in all-cause mortality, Yi said
Alt Immunes Pemvidutide Pemvidutide , a novel peptide-based GLP-1/glucagon dual receptor agonist developed by Altimmune, is garnering attention as a potential game-changer in the treatment of obesity and MASH (metabolic dysfunction-associated steatohepatitis)
To prevent delocalization Syntis Bio has developed GSEL, a mucoadhesive coating that adheres to the duodenal mucosa forming a depot that co-localizes peptide and PEs (Kanelli et al., 2025
Symptoms of a gallbladder attack include abdominal pain that lasts for hours, nausea and vomiting, fever, and jaundice
Final Thoughts GLP-1 medications and birth control may work together safely, but it takes a little awareness to make sure both are doing their job